Laurus Labs Reports Strong Financial Performance Amidst Operational Challenges in Pharmaceuticals Sector
Laurus Labs has recently experienced an evaluation adjustment reflecting its strong financial performance for the quarter ending March 2025. Key metrics include a notable operating profit to interest ratio of 7.46 times, net sales of Rs 1,720.30 crore, and a profit before tax of Rs 253.77 crore, highlighting its operational efficiency.
Laurus Labs, a prominent player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation adjustment that reflects its strong financial performance. The company reported a very positive financial performance for the quarter ending March 2025, showcasing significant metrics that contributed to the revision in its score. Key indicators include an operating profit to interest ratio reaching a notable 7.46 times, alongside net sales hitting Rs 1,720.30 crore. The company also reported its highest PBDIT at Rs 420.60 crore and a robust operating profit to net sales ratio of 24.45%. Furthermore, Laurus Labs achieved a profit before tax of Rs 253.77 crore and a profit after tax of Rs 233.67 crore, with earnings per share at Rs 4.33.
Despite these strengths, the company faces challenges, particularly with a debtors turnover ratio recorded at 2.77 times. Overall, the adjustments in Laurus Labs' evaluation underscore its solid market position and operational efficiency within the competitive pharmaceutical landscape.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
